These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13851323)

  • 1. Long-term results in treatment of diabetes mellitus with the sulphonylureas.
    GORMAN CK; WEAVER JA
    Br Med J; 1959 Dec; 2(5161):1214-7. PubMed ID: 13851323
    [No Abstract]   [Full Text] [Related]  

  • 2. The long-term use of sulphonylureas in diabetes mellitus.
    STOWERS JM; BEWSHER PD
    Lancet; 1962 Jan; 1(7221):122-5. PubMed ID: 13917576
    [No Abstract]   [Full Text] [Related]  

  • 3. Critical appraisal of sulfonylurea therapy of diabetes mellitus.
    BEASER SB
    JAMA; 1960 Nov; 174():1233-6. PubMed ID: 13688250
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of diabetes mellitus with sulfonylureas].
    DELBUE C
    Dia Med; 1960 Apr; 32():752-6. PubMed ID: 13815618
    [No Abstract]   [Full Text] [Related]  

  • 5. [The results of testing in administration of a new sulfonylurea derivative (metzhexamide) in oral diabetes therapy].
    HUHN R; MAIBAUER D
    Arztl Forsch; 1960 May; 14():I/269-70. PubMed ID: 14403908
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of diabetes with sulfonylureas].
    RAMBERT P
    Rev Med Fr; 1959 Dec; 40():601-3. PubMed ID: 24546209
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diabetes mellitus and sulfonylureas. Results of a year of chlorpropamide treatment].
    DELBUE C
    Rev Argent Endocrinol Metab; 1959 Dec; 5():259-72. PubMed ID: 13721532
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of diabetes with metahexamide.
    POLLEN RH; BARNES RH; TANNER DC; STIMSON WH; WILLIAMS RH
    Diabetes; 1960; 9():25-30. PubMed ID: 14433864
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical observations on the use of metahexamide in the oral treatment of diabetes mellitus].
    MUCCI A; LUCCHI R; DI MARCO G
    Minerva Med; 1961 Jan; 52():258-63. PubMed ID: 13773420
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical indications and contraindications for peroral therapy of diabetics with sulfonylurea preparations].
    STRAUZENBERG SE; HALLER H
    Z Gesamte Inn Med; 1959 Jun; 14():529-33. PubMed ID: 13835158
    [No Abstract]   [Full Text] [Related]  

  • 11. [The significance of sulfonylureas and biguanide for the treatment of diabetes mellitus].
    MEHNERT H
    Chemotherapia (Basel); 1961; 2():262-82. PubMed ID: 13768997
    [No Abstract]   [Full Text] [Related]  

  • 12. Metahexamide in diabetes therapy.
    MOSS JM; DELAWTER D
    Ann N Y Acad Sci; 1959 Sep; 82():614-7. PubMed ID: 14424617
    [No Abstract]   [Full Text] [Related]  

  • 13. ["Diabetic states" in pregnancy and their treatment with sulfonylurea derivatives. (Preliminary note)].
    LOPEZ-FERNANDIZ JR
    Hisp Med; 1960 Sep; 17():423-9. PubMed ID: 13763473
    [No Abstract]   [Full Text] [Related]  

  • 14. [The sulfonylureas in the treatment of the diabetic patient].
    RALLI EP
    Union Med Can; 1960 May; 89():618-26. PubMed ID: 14435982
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the problem of controlling blood picture in the continuous treatment of diabetic patients with sulfonylurea preparations].
    BLOECH J; KOENIGSTEIN RP; LACKNER P; LENHARDT A; MAEHR G
    Wien Klin Wochenschr; 1962 Feb; 74():94-5. PubMed ID: 13870067
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of sulfonylurea preparations on angina pectoris and intermittent claudication in diabetic subjects.
    FABRYKANT M; ASHE BI
    N Y State J Med; 1960 Mar; 60():841-5. PubMed ID: 13821251
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trial of amino-methylbenzol-sulphonyl-cyclohexylurea (metahexamide) in diabetics after failure of tolbutamide.
    HUSKISSON ID; JACKSON WP
    S Afr Med J; 1960 Jan; 34():34-5. PubMed ID: 14405589
    [No Abstract]   [Full Text] [Related]  

  • 18. [SULFONYLUREA SENSITIVITY: ITS SIGNIFICANCE IN THE THERAPY AND PROGNOSIS OF DIABETES MELLITUS].
    ANDREEV D
    Munch Med Wochenschr; 1964 Dec; 106():2259-62. PubMed ID: 14341467
    [No Abstract]   [Full Text] [Related]  

  • 19. [PROBLEMS OF LATE FAILURE OF ORAL SULFONYLUREA THERAPY OF DIABETES].
    STRAUZENBERG SE; HALLER H; MEYER H
    Schweiz Med Wochenschr; 1965 May; 95():628-36. PubMed ID: 14305109
    [No Abstract]   [Full Text] [Related]  

  • 20. [A contribution to late results of sulfonylurea therapy].
    BIBERGEIL H
    Med Klin; 1961 Oct; 56():1786-91. PubMed ID: 13868940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.